SERPINB2 and polycystic ovary syndrome: The females with PCOS are featured by hyperandrogenism, hyperinsulinemia, low endometrial glycodelin levels, and resulting hypofibrinolysis via elevated plasminogen activator inhibitor (PAI) activity [35,36].